Physician profile
John W Mcgrath
NPI 1659328086
$9,503.86
in general payments reported to CMS, 2019-2025
15 companies · $1,738 in 2025
The $1,738 reported for 2025 was more than what 88% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $607 · 2020: $4,218 · 2021: $274 · 2022: $482 · 2023: $1,657 · 2024: $528 · 2025: $1,738.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,524 · Food and Beverage: $1,291 · Education: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,524.00 |
| Food and Beverage | $1,291.30 |
| Education | $107.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $4,572.41 | 2019-2024 | |
| Genzyme Corporation | $3,411.75 | 2019-2025 | |
| Intersect Ent, INC. | $359.32 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $242.69 | 2021-2025 | Dupixent |
| Kaleo, INC. | $240.70 | 2019-2024 | Auvi-Q |
| Integra Lifesciences Corporation | $173.02 | 2024 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Medtronic USA, INC. | $150.00 | 2020 | |
| Stryker Corporation | $122.80 | 2019 | |
| Sanofi-Aventis U.S. LLC | $107.94 | 2025 | |
| Acclarent, INC | $37.23 | 2019-2021 | |
| Alk-Abello, INC | $26.16 | 2023 | Histamine Positive, Standardized Mite D. Farinae, Timothy, Standardized |
| Arbor Pharmaceuticals, INC. | $18.34 | 2019 | |
| Aerin Medical INC. | $15.55 | 2022 | |
| Phathom Pharmaceuticals, INC. | $14.00 | 2024 | Voquezna |
| Hikma Pharmaceuticals USA | $11.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mcgrath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.